NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Department of Biotechnology

Department of Biotechnology

New Delhi, Delhidbtindia.gov.in

Overview

The Department of Biotechnology (DBT) is a department of the Indian government under the Ministry of Science and Technology, established in 1986. Its primary mandate is to promote and accelerate the development, commercialization, and application of biotechnology in India across sectors like healthcare, agriculture, and the environment. While its main role is that of a government body, it also functions as an investor by providing funding and support to startups, researchers, and companies. This is largely carried out through various grants, schemes, and its public sector enterprise, the Biotechnology Industry Research Assistance Council (BIRAC), which was set up by the DBT to strengthen and empower biotech enterprises.

Portfolio Companies

16

Investments

Department of Biotechnology investments
CompanyDateStageLead
Nkure TherapeuticsApr 2023Pre SeedCo-investor
Fibroheal WoundcareSep 2021VC RoundCo-investor
1Cell.AiJul 2021GrantCo-investor
Huwel LifesciencesMay 2020DebtCo-investor
Curadev PharmaApr 2016GrantLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew Delhi, Delhi
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.